Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, Nishimura G, Robertson S, Sangiorgi L, Savarirayan R, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. 2019;179(12):2393–419.
PubMed
Google Scholar
Mogayzel PJ, Marcus CL. Skeletal dysplasias and their effect on the respiratory system. Paediatr Respir Rev. 2001;2(4):365–71.
CAS
PubMed
Google Scholar
Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet. 1986;23(4):328–32.
CAS
PubMed
PubMed Central
Google Scholar
Stoll C, Dott B, Roth MP, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin Genet. 1989;35(2):88–92.
CAS
PubMed
Google Scholar
Rasmussen SA, Bieber FR, Benacerraf BR, Lachman RS, Rimoin DL, Holmes LB. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet. 1996;61(1):49–58.
CAS
PubMed
Google Scholar
Camera G, Mastroiacovo P. Birth prevalence of skeletal dysplasias in the Italian Multicentric Monitoring System for Birth Defects. Prog Clin Biol Res. 1982;104:441–9.
CAS
PubMed
Google Scholar
Andersen PE Jr. Prevalence of lethal osteochondrodysplasias in Denmark. Am J Med Genet. 1989;32(4):484–9.
PubMed
Google Scholar
Waller DK, Correa A, Vo TM, Wang Y, Hobbs C, Langlois PH, Pearson K, Romitti PA, Shaw GM, Hecht JT. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A. 2008;146A(18):2385–9.
CAS
PubMed
PubMed Central
Google Scholar
Connor JM, Connor RA, Sweet EM, Gibson AA, Patrick WJ, McNay MB, Redford DH. Lethal neonatal chondrodysplasias in the West of Scotland 1970–1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet. 1985;22(2):243–53.
CAS
PubMed
Google Scholar
Krakow D, Alanay Y, Rimoin LP, Lin V, Wilcox WR, Lachman RS, Rimoin DL. Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis. Am J Med Genet A. 2008;146A(15):1917–24.
PubMed
PubMed Central
Google Scholar
Tretter AE, Saunders RC, Meyers CM, Dungan JS, Grumbach K, Sun CC, Campbell AB, Wulfsberg EA. Antenatal diagnosis of lethal skeletal dysplasias. Am J Med Genet. 1998;75(5):518–22.
CAS
PubMed
Google Scholar
Kallen B, Knudsen LB, Mutchinick O, Mastroiacovo P, Lancaster P, Castilla E, Robert E. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: an international feasibility study. Int J Epidemiol. 1993;22(1):107–15.
CAS
PubMed
Google Scholar
Parilla BV, Leeth EA, Kambich MP, Chilis P, MacGregor SN. Antenatal detection of skeletal dysplasias. J Ultrasound Med 2003;22(3):255–58.
PubMed
Google Scholar
Doray B, Favre R, Viville B, Langer B, Dreyfus M, Stoll C. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet. 2000;43(3–4):163–9.
CAS
PubMed
Google Scholar
Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med. 2009;11(2):127–33.
PubMed
PubMed Central
Google Scholar
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.
CAS
PubMed
Google Scholar
Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet. 1998;62(4):768–75.
CAS
PubMed
PubMed Central
Google Scholar
Quezada MS, Gil MM, Francisco C, Orosz G, Nicolaides KH. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10–11 weeks’ gestation and the combined test at 11–13 weeks. Ultrasound Obstet Gynecol. 2015;45(1):36–41.
CAS
PubMed
Google Scholar
Hou Y, Yang J, Qi Y, Guo F, Peng H, Wang D, Wang Y, Luo X, Li Y, Yin A. Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening. Hum Genomics. 2019;13(1):62.
CAS
PubMed
PubMed Central
Google Scholar
Wang E, Batey A, Struble C, Musci T, Song K, Oliphant A. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013;33(7):662–6.
CAS
PubMed
Google Scholar
Petersen AK, Cheung SW, Smith JL, Bi W, Ward PA, Peacock S, Braxton A, Van Den Veyver IB, Breman AM. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory. Am J Obstet Gynecol. 2017;217(6):691.e1–691.e6.
Google Scholar
Lo KK, Karampetsou E, Boustred C, McKay F, Mason S, Hill M, Plagnol V, Chitty LS. Limited clinical utility of non-invasive prenatal testing for subchromosomal abnormalities. Am J Hum Genet. 2016;98(1):34–44.
CAS
PubMed
Google Scholar
Chitty LS, Mason S, Barrett AN, McKay F, Lench N, Daley R, Jenkins LA. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn. 2015;35(7):656–62.
CAS
PubMed
PubMed Central
Google Scholar
Terasawa S, Kato A, Nishizawa H, Kato T, Yoshizawa H, Noda Y, Miyazaki J, Ito M, Sekiya T, Fujii T, et al. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders. Congenit Anom (Kyoto). 2019;59(1):4–10.
CAS
Google Scholar
Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, McCombs AK, Schmitt ES, Peacock S, Chen S, et al. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med. 2019;25(3):439–47.
CAS
PubMed
Google Scholar
Shin H, Sa JK, Bae JS, Koo H, Jin S, Cho HJ, Choi SW, Kyoung JM, Kim JY, Seo YJ, et al. Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas. Cancer Res Treat. 2020;52(1):41–50.
CAS
PubMed
Google Scholar
Kroigard AB, Thomassen M, Laenkholm AV, Kruse TA, Larsen MJ. Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data. PLoS ONE. 2016;11(3):e0151664.
PubMed
PubMed Central
Google Scholar
Verhoef TI, Hill M, Drury S, Mason S, Jenkins L, Morris S, Chitty LS. Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways. Prenat Diagn. 2016;36(7):636–42.
PubMed
PubMed Central
Google Scholar
Malcher C, Yamamoto GL, Burnham P, Ezquina SAM, Lourenco NCV, Balkassmi S, Antonio DSM, Hsia GSP, Gollop T, Pavanello RC, et al. Development of a comprehensive noninvasive prenatal test. Genet Mol Biol. 2018;41(3):545–54.
CAS
PubMed
PubMed Central
Google Scholar
Krakow D, Rimoin DL. The skeletal dysplasias. Genet Med. 2010;12(6):327–41.
PubMed
Google Scholar
Krakow D. Skeletal dysplasias. Clin Perinatol 2015;42(2):301–319.
PubMed
PubMed Central
Google Scholar
Wenger T, Miller D, Evans K. FGFR Craniosynostosis syndromes overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA); 1998.
Goncalves L, Jeanty P. Fetal biometry of skeletal dysplasias: a multicentric study. J Ultrasound Med. 1994;13(12):977–85.
CAS
PubMed
Google Scholar
Xue Y, Sun A, Mekikian PB, Martin J, Rimoin DL, Lachman RS, Wilcox WR. FGFR3 mutation frequency in 324 cases from the International Skeletal Dysplasia Registry. Mol Genet Genomic Med. 2014;2(6):497–503.
CAS
PubMed
PubMed Central
Google Scholar
French T, Savarirayan R. Thanatophoric dysplasia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA); 2004.
Legare JM. Achondroplasia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA); 1998.
Ornitz DM, Legeai-Mallet L. Achondroplasia: Development, pathogenesis, and therapy. Dev Dyn. 2017;246(4):291–309.
CAS
PubMed
PubMed Central
Google Scholar
Steiner RD, Basel D. COL1A1/2 Osteogenesis Imperfecta. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA); 2005.
Dalgleish R. The human type I collagen mutation database. Nucleic Acids Res. 1997;25(1):181–7.
CAS
PubMed
PubMed Central
Google Scholar
Dalgleish R. The Human Collagen Mutation Database 1998. Nucleic Acids Res. 1998;26(1):253–5.
CAS
PubMed
PubMed Central
Google Scholar
Hattapoğlu S, Durmaz MS. Radiological features of achondrogenesis type 1A: case report and review of the literature. Med J Obstet Gynecol. 2018;6(1):1115.
Google Scholar
Wenger TL, Hing AV, Evans KN. Apert Syndrome. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA); 2019.
Lajeunie E, Cameron R, El Ghouzzi V, de Parseval N, Journeau P, Gonzales M, Delezoide AL, Bonaventure J, Le Merrer M, Renier D. Clinical variability in patients with Apert’s syndrome. J Neurosurg. 1999;90(3):443–7.
CAS
PubMed
Google Scholar
Al-Namnam NM, Hariri F, Thong MK, Rahman ZA. Crouzon syndrome: Genetic and intervention review. J Oral Biol Craniofac Res. 2019;9(1):37–9.
CAS
PubMed
Google Scholar
Lin M, Lu Y, Sui Y, Zhao N, Jin Y, Yi D, Jiang M. Extremely severe scoliosis, heterotopic ossification, and osteoarthritis in a three-generation family with Crouzon syndrome carrying a mutant c.799T>C FGFR2. Mol Genet Genomic Med. 2019;7(9):e843.
PubMed
PubMed Central
Google Scholar
Lajeunie E, Heuertz S, El Ghouzzi V, Martinovic J, Renier D, Le Merrer M, Bonaventure J. Mutation screening in patients with syndromic craniosynostoses indicates that a limited number of recurrent FGFR2 mutations accounts for severe forms of Pfeiffer syndrome. Eur J Human Genet EJHG. 2006;14(3):289–98.
CAS
Google Scholar
Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, Tomkins S, Verloes A, Twigg SR, Rannan-Eliya S, et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet. 2002;70(2):472–86.
CAS
PubMed
PubMed Central
Google Scholar
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60.
CAS
PubMed
PubMed Central
Google Scholar
Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, Gabriel S, Meyerson M, Lander ES, Getz G. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213–9.
CAS
PubMed
PubMed Central
Google Scholar
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. Genome Project Data Processing S: The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25(16):2078–9.
PubMed
PubMed Central
Google Scholar
Lin JC, Fan CT, Liao CC, Chen YS. Taiwan Biobank: making cross-database convergence possible in the Big Data era. Gigascience. 2018;7(1):1–4.
PubMed
Google Scholar
Tang YA, Wang LY, Chang CM, Lee IW, Tsai WH, Sun HS. Novel Compound Heterozygous Mutations in CRTAP Cause Rare Autosomal Recessive Osteogenesis Imperfecta. Front Genet. 2020;11:897.
CAS
PubMed
PubMed Central
Google Scholar
Dello Russo C, Cesta A, Longo S, Barone MA, Cima A, Mesoraca A, Sparacino D, Viola A, Giorlandino C. Validation of extensive next-generation sequencing method for monogenic disorder analysis on cell-free fetal DNA: noninvasive prenatal diagnosis. J Mol Diagn. 2019;21(4):572–9.
Google Scholar
Perlado S, Bustamante-Aragones A, Donas M, Lorda-Sanchez I, Plaza J, Rodriguez de Alba M. Fetal genotyping in maternal blood by digital PCR: towards NIPD of monogenic disorders independently of parental origin. PLoS ONE. 2016;11(4):e0153258.
PubMed
PubMed Central
Google Scholar
Chitty LS, Khalil A, Barrett AN, Pajkrt E, Griffin DR, Cole TJ. Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenat Diagn. 2013;33(5):416–23.
CAS
PubMed
Google Scholar
New MI, Tong YK, Yuen T, Jiang P, Pina C, Chan KC, Khattab A, Liao GJ, Yau M, Kim SM, et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab. 2014;99(6):E1022-1030.
CAS
PubMed
PubMed Central
Google Scholar
Parks M, Court S, Cleary S, Clokie S, Hewitt J, Williams D, Cole T, MacDonald F, Griffiths M, Allen S. Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage. Prenat Diagn. 2016;36(4):312–20.
CAS
PubMed
PubMed Central
Google Scholar
Jenkins LA, Deans ZC, Lewis C, Allen S. Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice. Prenat Diagn. 2018;38(1):44–51.
PubMed
Google Scholar
Carothers AD, McAllion SJ, Paterson CR. Risk of dominant mutation in older fathers: evidence from osteogenesis imperfecta. J Med Genet. 1986;23(3):227–30.
CAS
PubMed
PubMed Central
Google Scholar
Goriely A, Hansen RM, Taylor IB, Olesen IA, Jacobsen GK, McGowan SJ, Pfeifer SP, McVean GA, Rajpert-De Meyts E, Wilkie AO. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet. 2009;41(11):1247–52.
CAS
PubMed
PubMed Central
Google Scholar
Goriely A, McVean GA, Rojmyr M, Ingemarsson B, Wilkie AO. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science. 2003;301(5633):643–6.
CAS
PubMed
Google Scholar
Goriely A, Wilkie AO. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet. 2012;90(2):175–200.
CAS
PubMed
PubMed Central
Google Scholar
Lemyre E, Azouz EM, Teebi AS, Glanc P, Chen MF. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update. Can Assoc Radio J. 1999;50(3):185–97.
CAS
Google Scholar
Shinde DN, Elmer DP, Calabrese P, Boulanger J, Arnheim N, Tiemann-Boege I. New evidence for positive selection helps explain the paternal age effect observed in achondroplasia. Hum Mol Genet. 2013;22(20):4117–26.
CAS
PubMed
PubMed Central
Google Scholar
Dan S, Yuan Y, Wang Y, Chen C, Gao C, Yu S, Liu Y, Song W, Asan, Zhu H, et al. Non-invasive prenatal diagnosis of lethal skeletal dysplasia by targeted capture sequencing of maternal plasma. PLoS ONE. 2016;11(7):e0159355.
Luo Y, Jia B, Yan K, Liu S, Song X, Chen M, Jin F, Du Y, Wang J, Hong Y, et al. Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening. Mol Genet Genomic Med. 2019;7(4):e00597.
PubMed
PubMed Central
Google Scholar